Navegação por autor "Corsini, Camila Amormino"
Itens para a visualização no momento 1-17 of 17
-
Analysis of vaccine efficacy against COVID-19 in oncology patients under active treatment
Assis, Jéssica Vieira de et al. | Data do documento: 2022 -
Avaliação da resposta imune contra SARS-CoV-2 analisada por até seis meses da infecção aguda e utilidade clínica de testes rápidos imunocromatográficos disponíveis no Brasil/
Corsini, Camila Amormino | Data do documento: 2022A atual pandemia de COVID-19 representa uma crise aguda de saúde e economia global, com consequências alarmantes na mortalidade e morbidade humana. Diante disso, há uma necessidade urgente de maiores estudos acerca da ... -
Booster dose of BNT162b2 after two doses of CoronaVac improves neutralization of SARS-CoV-2 Omicron variant
Campos, Guilherme R. F. et al. | Data do documento: 2022 -
Booster dose of BNT162b2 in a CoronaVac primary vaccination protocol improves neutralization of SARS-CoV-2 Omicron variant.
Campos, Guilherme R F et al. | Data do documento: 2022 -
COVID-19 in patients with chronic kidney disease: a 2-year study of incidence and mortality in relation to the variants of concern waves in Brazil
Almeida, Nathalie Bonatti Franco et al. | Data do documento: 2023 -
COVID-19 Rapid Antigen Test at Hospital Admission Associated to the Knowledge of Individual Risk Factors Allow Overcoming the Difficulty of Managing Suspected Patients in Hospitals.
Filgueiras, Priscilla Soares et al. | Data do documento: 2022 -
Dot blot platform as a novel diagnostic kit: rapid, accurate, and on-site detection of Schistosoma mansoni in urine samples of hard to detect individuals
Pedrosa, Maria Luysa de Camargos et al. | Data do documento: 2021 -
Evaluation of schistosomula crude antigen (SCA) as a diagnostic tool for Schistosoma mansoni in low endemic human population
Oyeyemi, Oyetunde Timothy et al. | Data do documento: 2021 -
Evaluation of the immune response against SARS-CoV-2 analyzed for up to six months of acute infection and clinical utility of rapid immunochromatographic tests available in Brazil
Corsini, Camila Amormino et al. | Data do documento: 2023 -
Humoral immune response of allergic subjects vaccinated against COVID-19
Oliveira, Laura Alves Ribeiro et al. | Data do documento: 2023 -
Immunita-001: Cross-sectional study of immunogenicity, safety and infection by SARS-CoV-2 in adults vaccinated with the inactivated virus vaccine (CoronaVac) in a two-dose protocol and heterologous booster doses
Gomes, Sarah Vieira Contin et al. | Data do documento: 2024 -
Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): a one year period follow up phase 4 study
Grenfell, Rafaella Fortini Queiroz et al. | Data do documento: 2022 -
Long COVID-19 syndrome: a 14-months longitudinal study during the two first epidemic peaks in Southeast Brazil
Miranda, Daniel Alvim Pena de et al. | Data do documento: 2022 -
Observational study of immunogenicity, effectiveness and reactogenicity in 6 months to 17 years age group of vaccines against COVID-19
Corsini, Camila Amormino et al. | Data do documento: 2023 -
Production of a monoclonal antibody against SARS-CoV-2 and determination of viral neutralization capacity
Almeida, Nathalie Bonatti Franco et al. | Data do documento: 2021 -
Rapid antigen test as a tool for the identification of SARS-CoV-2 infection and its potential as a self-testing device.
Filgueiras, Priscilla Soares et al. | Data do documento: 2023 -
Second booster dose improves antibody neutralization against BA.1, BA.5 and BQ.1.1 in individuals previously immunized with CoronaVac plus BNT162B2 booster protocol.
Campos, Guilherme Rodrigues Fernandes et al. | Data do documento: 2024